GeoVax Labs Investor Relations Material
Latest events
Q1 2025
GeoVax Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GeoVax Labs Inc
Access all reports
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which focuses on the development of human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle (VAP) vaccine platform. The company develops vaccines for the treatment of infectious diseases, such as malaria and tuberculosis; and immunotherapies for cancers. It also develops platforms containing novel antigens against various pathogens including hepatitis B virus, hepatitis C virus, influenza virus, Dengue fever virus and Plasmodium falciparum parasite; as well as replication-competent viruses for select human cancers.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GOVX
Country
🇺🇸 United States